Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/trevi-therapeutics-to-participate-in-upcoming-april-events-302107936.html
https://www.prnewswire.com/news-releases/trevi-therapeutics-adds-clinical-development-expertise-in-chronic-cough-to-leadership-team-302104511.html
https://www.biospace.com/article/releases/trevi-therapeutics-adds-clinical-development-expertise-in-chronic-cough-to-leadership-team/
https://www.prnewswire.com/news-releases/trevi-therapeutics-reports-fourth-quarter-and-year-end-2023-financial-results-and-provides-business-updates-302093708.html
https://www.prnewswire.com/news-releases/trevi-therapeutics-to-report-q4-and-year-end-2023-financial-results-and-provide-a-corporate-update-on-march-20-2024-302086846.html
https://www.prnewswire.com/news-releases/trevi-therapeutics-to-participate-in-the-oppenheimer-34th-annual-healthcare-life-sciences-conference-302053462.html
https://www.prnewswire.com/news-releases/trevi-therapeutics-announces-third-quarter-2023-financial-results-and-provides-business-update-301983762.html
https://www.prnewswire.com/news-releases/trevi-therapeutics-announces-the-initiation-of-its-phase-2a-river-clinical-trial-of-haduvio-for-refractory-chronic-cough-301975413.html
https://www.prnewswire.com/news-releases/trevi-therapeutics-announces-results-from-phase-2b3-prism-open-label-extension-study-of-haduvio-in-prurigo-nodularis-301955819.html
https://www.prnewswire.com/news-releases/trevi-therapeutics-to-participate-in-upcoming-september-events-301918186.html